scispace - formally typeset
S

Shu-Ming Huang

Researcher at Heilongjiang University of Chinese Medicine

Publications -  20
Citations -  2052

Shu-Ming Huang is an academic researcher from Heilongjiang University of Chinese Medicine. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 6, co-authored 12 publications receiving 1658 citations. Previous affiliations of Shu-Ming Huang include RIKEN Brain Science Institute.

Papers
More filters
Journal ArticleDOI

Synapse Loss and Microglial Activation Precede Tangles in a P301S Tauopathy Mouse Model

TL;DR: In this paper, the authors studied wild-type and P301S mutant human tau transgenic (Tg) mice and found that tangle formation was preceded by microglial activation.
Journal ArticleDOI

Somatostatin regulates brain amyloid beta peptide Abeta42 through modulation of proteolytic degradation.

TL;DR: The results indicate that the aging-induced downregulation of somatostatin expression may be a trigger for Aβ accumulation leading to late-onset sporadic Alzheimer disease, and suggest that som atostatin receptors may be pharmacological-target candidates for prevention and treatment of Alzheimer disease.
Journal ArticleDOI

Comprehensive behavioral phenotyping of calpastatin-knockout mice

TL;DR: Calpastatin-knockout mice showed decreased locomotor activity under stressful environments, and decreased acoustic startle response, but there was no significant change in hippocampus-dependent memory function, suggesting that calpastatin is likely to be more closely associated with affective rather than cognitive aspects of brain function.
Journal ArticleDOI

Valeriana amurensis improves Amyloid-beta 1-42 induced cognitive deficit by enhancing cerebral cholinergic function and protecting the brain neurons from apoptosis in mice.

TL;DR: Findings suggest that AD-EFV could ameliorate Aβ induced cognitive dysfunction through two underlying mechanisms: AD- EFV enhances the cerebral cholinergic function by increasing the secretion of ACh and enhancing the ChAT activity, and AD-EfV protects the brain neurons from A β induced apoptosis via activating the p-ERK and Bcl-2 signaling and suppressing the Bax pathways.
Journal ArticleDOI

Neuroprotective mechanism of Kai Xin San: upregulation of hippocampal insulin-degrading enzyme protein expression and acceleration of amyloid-beta degradation.

TL;DR: It is revealed that Kai Xin San facilitates hippocampal Aβ degradation and increases IDE expression, which leads, at least in part, to the alleviation of hippocampal neuron injury in rats.